Form 10-Q GLOBUS MEDICAL INC For: Sep 30

Go back to Form 10-Q GLOBUS MEDICAL INC For: Sep 30

Globus Medical (GMED) PT Raised to $80 at BofA Securities

November 6, 2024 5:57 AM EST

BofA Securities analyst Craig Bijou raised the price target on Globus Medical (NYSE: GMED) to $80.00 (from $55.00) while maintaining a Underperform rating.

The analyst comments "GMED continues to deliver beat and raises showing that it has managed the NuVasive integration better than... More